Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

TY - JOUR

T1 - Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

AU - Appleby, Niamh

AU - Cullen, Ruth

AU - Painter, Daniel Edwin

AU - Smith, Alexandra Gwen

AU - Roman, Eve

AU - Barrans, Sharon

AU - O'Connor, Sheila

AU - Burton, Catherine

AU - Jack, Andrew S.

AU - Owen, Roger G

AU - Tooze, Reuben

PY - 2015/12/3

Y1 - 2015/12/3

N2 - Plasmablastic lymphoma (PBL) is a rare, aggressive lymphoma of differentiated B lymphocytes. PBL sits at the boundary between Diffuse Large B Cell Lymphoma (DLBCL) and plasmablastic myeloma, and is more frequent amongst HIV positive patients. With an increasing divergence between therapy for myeloma and lymphoma and a deficit of prospective studies, the nature of PBL and outcome on current therapy merits further assessment.

AB - Plasmablastic lymphoma (PBL) is a rare, aggressive lymphoma of differentiated B lymphocytes. PBL sits at the boundary between Diffuse Large B Cell Lymphoma (DLBCL) and plasmablastic myeloma, and is more frequent amongst HIV positive patients. With an increasing divergence between therapy for myeloma and lymphoma and a deficit of prospective studies, the nature of PBL and outcome on current therapy merits further assessment.

UR - https://ash.confex.com/ash/2015/webprogramscheduler/Paper84919.html

U2 - 10.1182/blood.V126.23.3924.3924

DO - 10.1182/blood.V126.23.3924.3924

M3 - Meeting abstract

SN - 0006-4971

VL - 126

SP - 2021

JO - Blood

JF - Blood

IS - 23

T2 - American Society of Hematology

Y2 - 7 December 2015

ER -